Smith & Nephew is a global medical technology company operating across orthopaedics, sports medicine, ENT, and advanced wound management. The company delivers solutions for tissue repair, regeneration, and replacement, serving millions of patients annually across more than 100 countries. With over 18,000 employees and listings on the LSE (FTSE 100) and NYSE, it operates at significant scale.
The company's technical portfolio spans robotics-assisted surgery, bioinductive implants, and negative pressure wound therapy. Notable products include the CORI Surgical System for robot-assisted procedures, PICO for negative pressure wound therapy, and REGENETEN, a bioinductive implant designed to promote tissue regeneration. These offerings reflect ongoing investment in both established and emerging medical technologies.
Smith & Nephew's operations span diverse technical domains - from software and systems integration supporting surgical robotics to materials science and biomechanics underlying implant design, to digital health and data analytics across wound management platforms. The breadth of technical challenges across these domains creates varied opportunities for engineering and technology expertise.
